Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ready-to-use dialysis fluids tested in real-world ICU study

NCT ID NCT06983509

Knowledge-focused Sponsor: Vantive Health LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracked 228 critically ill patients in China who needed continuous kidney dialysis. Doctors used pre-mixed solutions instead of custom-mixed ones to see how well they worked in everyday hospital care. The goal was to gather information on filter life, blood chemistry, and ease of use, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

228 people

The number who actually took part.

Started

Oct 2024

Finished

Sep 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Critically ill adult patients who require CRRT with one of the following pre-mixed solutions: Regiocit, Biphozyl, or Prismasol 2.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 ≤ age \< 80 years old. * Patients admitted to the intensive care unit (ICU) and in need of CRRT. * Patients are willing to receive CRRT with at least one of three pre-mixed solutions: Regiocit, Biphozyl, or Prismasol 2. Exclusion Criteria: * Patients with chronic kidney failure who are receiving maintenance dialysis. * Patients expected to require the premixed solution for less than 24 hours. * Patients who are allergic or have contraindications to components of pre-mixed solutions, as determined by the investigators. * Patients who have participated in other interventional studies within the last 30 days. * Patients who are pregnant, breastfeeding, or abortus imminence.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Renal insufficiency are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

kidney failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Renal insufficiency

Contacts and locations

Locations

  • Beijing Anzhen Hospital, Capital Medical University

    Beijing, 100029, China

  • Beijing Chao-yang Hospital, Capital Medical University

    Beijing, 100020, China

  • Shanghai East Hospital

    Shanghai, 200120, China

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, 400016, China

  • The First People's Hospital of Guangzhou

    Guangzhou, 510180, China

  • Xuanwu Hospital Capital Medical University

    Beijing, 100053, China

  • Zhejiang Provincial People's Hospital

    Hangzhou, 310014, China

  • ZhongShan Hospital Fudan University

    Shanghai, 200032, China

  • Zhongnan Hospital, Wuhan University

    Wuhan, 430071, China

  • Zhujiang Hospital, Southern Medical University

    Guangzhou, 510280, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.